Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 27,418 | 29,584 | 28,202 | 33,858 | 28,635 |
| Cost of Goods | 12,439 | 13,629 | 12,048 | 15,118 | 12,818 |
| Gross Profit | 14,979 | 15,955 | 16,154 | 18,740 | 15,817 |
| Operating Expenses | 16,783 | 16,356 | 16,322 | 17,116 | 15,745 |
| Operating Income | -1,365 | 228 | -120 | 1,742 | 890 |
| Interest Expense | 1,348 | 1,376 | 1,405 | 1,532 | 1,458 |
| Other Income | 39 | 16 | -269 | -165 | -340 |
| Pre-tax Income | -2,674 | -1,132 | -1,794 | 45 | -908 |
| Income Tax | -54 | -885 | 576 | -3,260 | -652 |
| Net Income Continuous | -2,620 | -247 | -2,370 | 3,305 | -256 |
| Net Income Discontinuous | N/A | N/A | N/A | -443 | N/A |
| Net Income | $-2,620 | $-247 | $-2,370 | $2,862 | $-256 |
| EPS Basic Total Ops | -0.70 | -0.10 | -0.60 | 0.80 | -0.10 |
| EPS Basic Continuous Ops | -0.69 | -0.07 | -0.63 | 0.90 | -0.10 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.11 | N/A |
| EPS Diluted Total Ops | -0.70 | -0.10 | -0.60 | 0.80 | -0.10 |
| EPS Diluted Continuous Ops | -0.69 | -0.07 | -0.63 | 0.90 | -0.10 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.11 | N/A |
| EBITDA(a) | $681 | $2,196 | $1,939 | $4,226 | $2,820 |